grant_single_labels|summary

grant_single|eligibleFinancing
  • grant_single|noCondition
grant_single|deadlines
  • grant_single|openingDate November 14, 2019
grant_single|financingType
Researchers And Facilities
grant_single|eligibleIndustries
  • Manufacturing
  • Professional, scientific and technical services
  • Health care and social assistance
grant_single|grantors
  • National Research Council Canada (NRC)
  • Government of Canada
grant_single|status
grant_card_status|open

grant_single_labels|preview

Fee-for-service cell culture pilot plant offering development and scale-up for the production of biologics and vaccines using CHO, HEK 293 and other animal cell expression systems.

grant_single_labels|projects

This grant facilitates the development and optimization of bioprocesses for biologics and vaccines, focusing on leveraging advanced cell culture systems. Eligible projects aim to enhance scale-up, purification, and production capabilities.
  • Development and scale-up of batch, fed-batch, or perfusion cell culture processes up to 500 L scale for biologics production.
  • Scale-up of viral production and purification processes.
  • Scale-up of transient transfection processes.
  • Development of cell culture media and feeding strategies for process optimization.
  • In-process assay development to ensure robust production outcomes.
  • Customized, hands-on training on bioreactor operation up to 500 L scale for technology transfer and workforce development.
grant_single|admissibleProjectsExample

$ 220,000

Development of custom cell culture media for the optimization of an antibody production process

$ 200,000

Conducting hands-on training for bioreactor operation up to 500 L scale

$ 250,000

Developing a 500 L scale bioreactor process for vaccine production using CHO cells

$ 270,000

Development and scale-up of a perfusion cell culture process for biologics production

$ 280,000

Optimization of transient transfection processes for the production of therapeutic proteins

$ 300,000

Scale-up of viral production processes for gene therapy applications

grant_single_labels|admissibility

Eligibility criteria:
  • Canadian biotechnology companies
  • Businesses involved in pilot-scale production and purification of biologics, viral vectors, and vaccines

grant_eligibility_criteria|who_can_apply

This program is ideal for biotechnology companies involved in the pilot-scale production and purification of recombinant proteins, viral vectors, and vaccines. It is particularly suited for those aiming to optimize cGMP-compatible bioprocesses and work towards a robust Canadian biomanufacturing sector. The program supports the scale-up process using advanced bioprocessing services and equipment.

grant_eligibility_criteria|eligible_expenses

The grant supports projects focused on advancing bioprocessing services and equipment for the production of biologics and vaccines. It emphasizes process development and scale-up for various cell culture systems and optimization strategies.
  • Development and scale-up of batch, fed-batch, or perfusion cell culture processes up to 500 L scale for biologics production.
  • Scale-up of viral production and purification processes.
  • Scale-up of transient transfection processes.
  • Development of cell culture media and feeding strategies for process optimization.
  • In-process assay development.
  • Customized, hands-on training on bioreactor operation up to 500 L scale.

grant_eligibility_criteria|zone

This grant is aimed at fostering the Canadian biomanufacturing sector, suggesting a focus on companies within Canada. The explicit geographical eligibility details are not provided in the available text.

grant_single_labels|criteria

Grant applications will be assessed based on key criteria including scientific excellence, feasibility, impact, and alignment with the objectives of the Human Health Therapeutics Research Centre.
  • Scientific excellence
  • Feasibility of the proposed project
  • Potential impact of the project
  • Alignment with the objectives of the Human Health Therapeutics Research Centre

grant_single_labels|apply

Here are the steps to submit an application for this grant:
  • Step 1: Contact the Research Centre
    • Reach out to Martin Loignon, the Team Leader for Cell Culture Scale-Up, to express your interest in the services offered by the NRC’s Human Health Therapeutics Research Centre.
    • Obtain detailed information about the application process, requirements, and any supporting documentation needed.
  • Step 2: Prepare Application
    • Compile a comprehensive project proposal detailing your specific needs for process development and scale-up using the Centre’s services.
    • Include objectives, expected outcomes, and how your project aligns with the NRC’s capabilities in biologics and vaccine production.
    • Gather any necessary supporting documents like technical specifications and financial plans.
  • Step 3: Submit Application
    • Follow the instructions provided by the contact at the Research Centre to submit your proposal and supporting documents.
    • Ensure all documents are complete and submitted before any communicated deadline.
  • Step 4: Verification
    • Wait for a confirmation from the NRC acknowledging receipt of your application.
    • Ensure your contact details are correct for any follow-up questions or requests for additional information.

grant_single_labels|otherInfo

Here are additional relevant details for this grant:
  • The NRC’s Human Health Therapeutics Research Centre offers specific expertise in developing high-performance liquid chromatography (HPLC) and cell-based assays.
  • The facility enables the transition from bench-scale process optimization to up to 500 L scale production.
  • The team provides customized, hands-on training on bioreactor operation up to a 500 L scale.
  • The cell culture pilot plant functions as an ideal facility for emerging technologies and facilitates transfer of optimized bioprocesses to a CMO.
  • The NRC owns proprietary versions of the HEK293 cell line, namely HEK293SF-3F6 and HEK293-6E.

grant_single_labels|documents

NRC — Cell Culture Pilot Plant

Apply to this program

More grants like this

Electricity Management Systems -
Grant and Fundinggrant_card_status|open
Money for energy management systems in Quebec
Roulez Vert — Rebate for charging station at work -
Grant and Fundinggrant_card_status|suspending
Get financial aid to install electric charging stations at your Quebec business
Economic development program to help revitalize territories (DEPART) -
Grant and Fundinggrant_card_status|open
DÉPART supports economic diversification and growth in targeted areas
NovaScience Program - Support for projects in scientific culture and innovation -
Grant and Fundinggrant_card_status|closed
NovaScience promotes scientific culture and innovation development
PROMPT — PARTENAR-IA — Industry -
Partnering and CollaborationGrant and Fundinggrant_card_status|open
Funding for Quebec innovative collaborations in AI for ICT
ÉcoPerformance — Standard Analysis Stream -
Grant and Fundinggrant_card_status|open
Complete analysis of greenhouse gas reduction options for Quebec companies
ESSOR – Component 2: Support for investment projects promoting productivity and business expansion -
Loans and Capital investmentsgrant_card_status|open
Investment support for productivity and business expansion
NovaScience Program — Support for employment in research and innovation -
Grant and Fundinggrant_card_status|closed
NovaScience supports innovation job integration in Quebec businesses
MTL + ECOMMERCE — Digital Accelerator -
Grant and Fundinggrant_card_status|closed
Support Quebec SMEs in digital transformation and growth
Financial Assistance Program for the Promotion of French – stream 1 -
Grant and Fundinggrant_card_status|closed
Money to promote the use of French in the office